PRIZES to win! PROMOTIONS

Close Notification

Your cart does not contain any items

The Correlation Between Pre-Treatment Inflammatory Markers and the Treatment of Breast Cancer

Jiaju Xu

$81.95   $69.31

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Eliva Press
11 September 2024
There is increasing evidence demonstrating that systemic inflammation is critically involved in promoting tumor progression and metastasis. Inflammatory markers, including neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) or lymphocyte/monocyte ratio (LMR) may partially reflect the immune function in the body. Numerous researches have shown that increased NLR, PLR and LMR are associated with poor prognosis in BC.

The predictive significance of pre-treatment NLR / PLR / LMR for and neoadjuvant therapy (NAC) efficacyis not fully understood, and the results were controversial. Herein, this study was designed to assess the correlation of pre-treatment NLR, PLR and LMR with menopausal status and Ki67 LI, and to determine whether they were predictive factors for NAC responses. This is the first case report describing a patient with non-small cell lung cancer (NSCLC) harboring two rare human epidermal growth factor receptor 2 (HER2) exon 21 insertion mutations, who responded to furmonertinib treatment.
By:  
Imprint:   Eliva Press
Dimensions:   Height: 229mm,  Width: 152mm,  Spine: 4mm
Weight:   104g
ISBN:   9789999321624
ISBN 10:   9999321623
Pages:   68
Publication Date:  
Audience:   General/trade ,  ELT Advanced
Format:   Paperback
Publisher's Status:   Active

See Also